Therefore, a prospective study, including a food frequency questionnaire for detailed history of health supplement use, accurate anthropometric measurements, and biomarkers such as serum AST, ALT, albumin, fatty acid levels, and fatty acid%, is required to determine the effects of the NAFLD-presence factors on stroke onset or prevention. This evidence concerns the gene GPT and stroke disorder.